二环丙胺 | 73121-95-6

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 二环丙胺
• 英文名称: di(cyclopropyl)amine
• 英文别名: Dicyclopropylamine；N-cyclopropylcyclopropanamine
• CAS: 73121-95-6
• 化学式: C₆H₁₁N
• 分子量: 97.16
• InChiKey: JKWKFBUUNGGYBP-UHFFFAOYSA-N

物化性质

• 沸点：
  136℃
• 密度：
  0.98
• 闪点：
  19℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  二环丙胺 在 二叔丁基过氧化物 作用下， 以 various solvent(s) 为溶剂， 生成
  参考文献：
  名称：

  Kinetic applications of electron paramagnetic resonance spectroscopy. 35. The search for a dialkylaminyl rearrangement. Ring opening of N-cyclobutyl-N-n-propylaminyl

  摘要：

  DOI：

  10.1021/ja00521a052
• 作为产物：
  描述：

  二环丙胺盐酸盐 在 titanium(IV) isopropylate 、 sodium hydroxide 、 四丁基氯化铵 作用下， 以 四氢呋喃 、 乙醚 、 氯仿 、 水 为溶剂， 反应 14.0h， 生成 二环丙胺
  参考文献：
  名称：

  Radical Cations of Trialkylamines:  ESR Spectra and Structures

  摘要：

  Novel syntheses of cyclopropyldiisopropylamine (15), di-tert-butylcyclopropylamine (16), dicyclopropylisopropylamine (17), and tricyclopropylamine (18) are described. Hyperfine data were determined by ESR spectroscopy for the radical cations of these trialkylamines, as well as for those of ethyldiisopropylamine (10), diisopropyl-n-propylamine (11), dicyclohexylethylamine (12), diisopropyl-3-pentylamine (14), and 1-azabicyclo[3.3.3]undecane (manxine; 27). The radical cation of triisopropylamine (13) was reexamined under conditions of improved spectral resolution. Coupling constants of the N-14 nucleus and the beta-protons in the radical cations of 18 trialkylamines provide reliable information about the geometries of these species, which are confirmed by theoretical calculations. With the exception of a few oligocyclic amines, for which flattening is impaired by the rigid molecular framework, all of the radical cations should be planar. Correlation between the observed coupling constants of the beta-protons and the calculated values of the dihedral angle theta, defining the conformation of the alkyl substituent or the azacycloalkane, is verified. Upon oxidation, striking changes occur for those amines that have cyclopropyl substituents, because of the tendency of these groups to assume a perpendicular conformation in the neutral amines and a bisected orientation in the corresponding radical cations.

  DOI：

  10.1021/jo990458n

文献信息

• Direct Access to α-Oxoketene Aminals via Copper-Catalyzed Formal Oxyaminalization of Alkenes under Mild Conditions
  作者：Lu Wang、Chaorong Qi、Tianzuo Guo、Huanfeng Jiang

  DOI：10.1021/acs.orglett.9b00518

  日期：2019.4.5

  A copper-catalyzed four-component formal oxyaminalization of alkenes with Togni’s reagent and amines using molecular oxygen as both the oxidant and oxygen source has been developed for the first time, offering a straightforward and efficient method for the synthesis of a range of structurally diverse α-oxoketene aminals. The use of cheap copper catalyst and readily available substrates, excellent functional

  首次开发了使用Togni试剂和胺通过分子氧作为氧化剂和氧源的铜催化烯烃的四组分甲醛缩醛化方法，这为合成一系列结构多样的α提供了一种简单有效的方法-环氧丁烷缩醛。该策略的吸引人之处在于使用廉价的铜催化剂和易于获得的底物，出色的官能团耐受性，广泛的底物范围，温和的条件以及简单的步骤。
• [EN] BICYCLIC HETEROARYL AMINE COMPOUNDS AS PI3K INHIBITORS<br/>[FR] COMPOSÉS AMINE HÉTÉROARYLES BICYCLIQUES UTILISÉS COMME INHIBITEURS DE LA PI3K
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2016064957A1

  公开（公告）日：2016-04-28

  Disclosed are compounds of Formula (I) or a salt thereof; wherein: X is N or CH; Q1 is: (i) C1, Br, I, -CN, -CH3, or -CF3; (ii) a 5-membered heteroaryl selected from pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, and thiadiazolyl; (iii) a 6?membered heteroaryl selected from pyridinyl, pyridazinyl, and pyrimidinyl; or (iv) a bicyclic heteroaryl selected from indolyl, pyrrolopyridinyl, pyrazolopyridinyl and benzo[d]oxazolyl; wherein each of said 5-membered, 6-membered, and bicyclic heteroaryl is substituted with zero to 1 Ra and zero to 1 Rb; and R1, R2, R3, R4, R5, R6, Ra, and Rb are defined herein. Also disclosed are methods of using such compounds as modulators of PI3K, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases.

  公开了Formula (I)或其盐的化合物；其中：X为N或CH；Q1为：(i) C1、Br、I、-CN、-CH3或-CF3；(ii)从吡咯基、吡唑基、咪唑基、噁唑基、噻唑基、三唑基、噁二唑基和噻二唑基中选择的5-成员杂芳基；(iii)从吡啶基、吡啶嗪基和嘧啶基中选择的6-成员杂芳基；或(iv)从吲哚基、吡咯吡啶基、吡唑吡啶基和苯并[d]噁唑基中选择的双环杂芳基；其中所述的5-成员、6-成员和双环杂芳基中的每一个都被零至1个Ra和零至1个Rb取代；R1、R2、R3、R4、R5、R6、Ra和Rb在此处被定义。还公开了使用这些化合物作为PI3K调节剂的方法，以及包含这些化合物的药物组合物。这些化合物在治疗、预防或减缓炎症性和自身免疫性疾病方面是有用的。
• Synthesis and Cytostatic Activity of N-[2-(Phosphonomethoxy)alkyl] Derivatives of N6-Substituted Adenines, 2,6-Diaminopurines and Related Compounds
  作者：Antonín Holý、Ivan Votruba、Eva Tloušťová、Milena Masojídková

  DOI：10.1135/cccc20011545

  日期：——

  N⁶-Substituted adenine and 2,6-diaminopurine derivatives of 9-[2-(phosphonomethoxy)- ethyl] (PME), 9-[(R)-2-(phosphonomethoxy)propyl] [(R)-PMP] and enantiomeric (S)-PMP series were synthesized by reactions of primary or secondary amines with 6-chloro-9-[2-(diisopropoxyphosphoryl)methoxy]alkyl}purines (26-28) or 2-amino-6-chloro-9-[2-(diisopropoxy- phosphoryl)methoxy]alkyl}purines (29-31) followed by treatment of the diester intermediates32with bromo(trimethyl)silane and hydrolysis. Diesters32were also obtained by reaction ofN⁶-substituted purines with synthons23-25bearing diisopropoxyphosphoryl group. Alkylation of 2-amino-6-chloropurine (9) with diethyl [2-(2-chloroethoxy)ethyl]phosphonate (148) gave the diester149which was analogously converted toN⁶-substituted 2,6-diamino- 9-[2-(2-phosphonoethoxy)ethyl]purines151-153. Alkylation ofN⁶-substituted 2,6-diaminopurines with (R)-[(trityloxy)methyl]oxirane (155) followed by reaction of thus-obtained intermediates156with dimethylformamide dimethylacetal and condensation with diisopropyl [(tosyloxy)methyl]phosphonate (158) followed by deprotection of the intermediates159gaveN⁶-substituted 2,6-diamino-9-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]purines160-163. The highest cytostatic activityin vitrowas exhibited by the followingN⁶-derivatives of 2,6-diamino-9-[2-(phosphonomethoxy)ethyl]purine (PMEDAP): 2,2,2-trifluoroethyl (53), allyl (54), [(2-dimethylamino)ethyl] (68), cyclopropyl (75) and dimethyl (91). In CCRF-CEM cells, the cyclopropyl derivative75is deaminated to the guanine derivative PMEG (3) which is then converted to its diphosphate.

  N6-取代腺嘌呤和2,6-二氨基嘌呤衍生物9-[2-(磷酸甲氧基)-乙基]（PME）、9-[(R)-2-(磷酸甲氧基)丙基] [(R)-PMP] 和对映体(S)-PMP 系列通过初级或次级胺与6-氯-9-[2-(二异丙氧磷酰基)甲氧基]烷基}嘌呤（26-28）或2-氨基-6-氯-9-[2-(二异丙氧磷酰基)甲氧基]烷基}嘌呤（29-31）的反应合成，随后用溴化(三甲基)硅烷和水解处理二酯中间体32。二酯32也可通过N6-取代嘌呤与带有二异丙氧磷酰基的合成物23-25发生反应获得。2-氨基-6-氯嘌呤（9）与二乙基[2-(2-氯乙氧基)乙基]磷酸酯（148）的烷基化反应得到二酯149，类似地转化为N6-取代2,6-二氨基-9-[2-(2-磷酸乙氧基)乙基]嘌呤151-153。N6-取代2,6-二氨基嘌呤与(R)-[(三苄氧基)甲基]环氧乙烷（155）发生烷基化反应，随后用二甲基甲酰胺二甲基缩醛和与异丙基[(对甲苯磺酰氧基)甲基]磷酸酯（158）发生缩合反应，然后去保护中间体159得到N6-取代2,6-二氨基-9-[(S)-3-羟基-2-(磷酸甲氧基)丙基]嘌呤160-163。体外细胞毒活性最高的是以下2,6-二氨基-9-[2-(磷酸甲氧基)乙基]嘌呤（PMEDAP）的N6-衍生物：2,2,2-三氟乙基（53）、烯丙基（54）、[(2-二甲基氨基)乙基]（68）、环丙基（75）和二甲基（91）。在CCRF-CEM细胞中，环丙基衍生物75被脱氨基化为鸟嘌呤衍生物PMEG（3），然后转化为其二磷酸盐。
• 一种乐伐替尼杂质及其制备方法
  申请人：南京方生和医药科技有限公司

  公开号：CN114634446A

  公开（公告）日：2022-06-17

  本发明公开了一种乐伐替尼新杂质II及其制备方法，该制备方法是将化合物I、二环丙胺或其盐、碱溶于有机溶剂中，加热至反应温度，保温反应得到化合物II。该杂质II可作为乐伐替尼有关物质检测用的对照品，用于乐伐替尼中间体及乐伐替尼原料药的纯度控制。
• Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors
  作者：Long Zhang、Yingying Yang、Haojie Zhou、Qingmei Zheng、Yuhao Li、Shansong Zheng、Shuyong Zhao、Dong Chen、Chuanwen Fan

  DOI：10.1016/j.ejmech.2015.08.026

  日期：2015.9

  We have developed a series of 6, 7-disubstituted-4-(arylamino) quinazoline derivatives that functioned as irreversible EGFR inhibitors, and these compounds exhibited excellent enzyme inhibition potency. As compared with afatinib, some of them showed significantly enhanced activities towards H1975 cells (EGFR-T790M). Furthermore, the optimized compounds 7q and 8f also demonstrated good pharmacokinetic profiles, oral bioavailability as well as excellent in vivo efficacy in H1975 and HCC827 xenografts at a non-toxic dose. Based on the improved safety and efficacy against EGFR-T790M resistance, 7q and 8f are promising candidates for further studies. (C) 2015 Elsevier Masson SAS. All rights reserved.